Operating Lease, Right-of-Use Asset of Intellia Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intellia Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Intellia Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $105,955,000, a 52% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Intellia Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $105,955,000 -$113,337,000 -52% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $117,883,000 +$17,552,000 +17% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $129,045,000 +$23,633,000 +22% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $137,979,000 +$27,555,000 +25% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $219,292,000 +$103,917,000 +90% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $100,331,000 -$18,444,000 -16% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $105,412,000 -$18,138,000 -15% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $110,424,000 -$17,841,000 -14% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $115,375,000 -$17,701,000 -13% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $118,775,000 +$17,485,000 +17% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $123,550,000 +$49,775,000 +67% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $128,265,000 +$51,792,000 +68% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $133,076,000 +$53,933,000 +68% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $101,290,000 +$19,502,000 +24% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $73,775,000 +$72,375,000 +5170% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $76,473,000 -$1,439,000 -1.8% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $79,143,000 +$40,029,000 +102% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $81,788,000 +$59,578,000 +268% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $1,400,000 -$22,069,000 -94% 30 Jun 2021 10-K 24 Feb 2022 2021 FY
Q1 2021 $77,912,000 +$52,994,000 +213% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $39,114,000 +$19,977,000 +104% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $22,210,000 +$1,547,000 +7.5% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $23,469,000 +$2,546,000 +12% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $24,918,000 +$3,906,000 +19% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $19,137,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $20,663,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $20,923,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $21,012,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.